Sponsored Links
| Yellox™, The First And Only Twice-Daily Ocular NSAID, Approved By The European Commission Following Positive Opinion From CHMP |
 |
 |
 |
| Medical News - Eye Health | |||
|
CROMA Pharma, GmbH (CROMA), a private global specialty pharmaceutical and surgical company and Bausch + Lomb, the global eye health company, today announced the approval of Yellox ™ (Bromfenac sodium sesquihydrate) by the European commission... Read more: Eye Health / Blindness News From Medical News Today
|